| MeSH_gene2pubmed |
B_12_15 |
D006509 |
Hepatitis B |
9/30 |
263/26076 |
1.11994888215789e-11 |
1.52049530589436e-09 |
9.8680325653912e-10 |
EIF2AK2/IRF7/IRF9/MX1/OAS1/OAS2/OAS3/STAT1/TNFSF10 |
9 |
| MeSH_gene2pubmed |
B_12_15 |
D050839 |
Interferon Regulatory Factor-7 |
7/30 |
96/26076 |
1.39378632101947e-11 |
1.78714379384052e-09 |
1.15985844140977e-09 |
IFI44/IRF7/IRF9/ISG15/OAS1/STAT1/TRIM22 |
7 |
| WikiPathways |
B_12_15 |
WP4197 |
Immune response to tuberculosis |
6/24 |
22/8836 |
1.4798734520091e-11 |
7.54735460524641e-10 |
5.76371765519334e-10 |
IFIT3/IFITM1/IRF9/MX1/OAS1/STAT1 |
6 |
| GO |
B_12_15 |
GO:0060337 |
type I interferon-mediated signaling pathway |
7/28 |
85/18986 |
3.07434237087417e-11 |
1.14519253315063e-09 |
7.0588518910203e-10 |
IFITM1/IRF7/ISG15/OAS1/OAS2/OAS3/STAT1 |
7 |
| GO |
B_12_15 |
GO:0071357 |
cellular response to type I interferon |
7/28 |
86/18986 |
3.34350428286602e-11 |
1.17219326622832e-09 |
7.22528170105412e-10 |
IFITM1/IRF7/ISG15/OAS1/OAS2/OAS3/STAT1 |
7 |
| KEGG |
B_12_15 |
hsa05171 |
Coronavirus disease - COVID-19 |
9/15 |
238/8541 |
3.7728274704944e-11 |
4.43307227783092e-10 |
2.87926306958783e-10 |
EIF2AK2/IRF9/ISG15/MX1/MX2/OAS1/OAS2/OAS3/STAT1 |
9 |
| MeSH_gene2pubmed |
B_12_15 |
D050795 |
STAT2 Transcription Factor |
7/30 |
114/26076 |
4.74499812849044e-11 |
5.76392404239787e-09 |
3.74079353841657e-09 |
IRF7/IRF9/ISG15/MX1/NMI/STAT1/TNFSF10 |
7 |
| MeSH_gene2pubmed |
B_12_15 |
D019698 |
Hepatitis C, Chronic |
9/30 |
317/26076 |
5.91996185603512e-11 |
6.83163598186453e-09 |
4.43373985323051e-09 |
EIF2AK2/IFI44/IRF7/IRF9/ISG15/MX1/OAS1/STAT1/TNFSF10 |
9 |
| reactome |
B_12_15 |
R-HSA-1169408 |
ISG15 antiviral mechanism |
7/24 |
73/11146 |
1.21972156867522e-10 |
3.44571343150749e-09 |
2.18265964920829e-09 |
EIF2AK2/HERC5/ISG15/MX1/MX2/STAT1/UBE2L6 |
7 |
| MeSH_gene2pubmed |
B_12_15 |
D024882 |
Drug Resistance, Viral |
6/30 |
67/26076 |
1.29403755086607e-10 |
1.42220888923756e-08 |
9.23015255580156e-09 |
EIF2AK2/MX1/OAS1/OAS2/OAS3/STAT1 |
6 |